Armata Pharmaceuticals Q4 EPS $(0.55) Misses $(0.35) Estimate, Sales $1.53M Beat $860.00K Estimate
Armata Pharmaceuticals Q4 EPS $(0.55) Misses $(0.35) Estimate, Sales $1.53M Beat $860.00K Estimate
Armata Pharmaceuticals第四季度每股收益美元（0.55）未達到預期（0.35）美元，153萬美元銷售額超過86.00萬美元的預期
Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $(0.35) by 57.14 percent. This is a 89.66 percent decrease over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $1.53 million which beat the analyst consensus estimate of $860.00 thousand by 77.67 percent. This is a 45.39 percent increase over sales of $1.05 million the same period last year.
Armata Pharmicals（美國證券交易所股票代碼：ARMP）公佈的季度虧損爲每股0.55美元，比分析師普遍預期的0.35美元（0.35美元）低57.14％。這比去年同期每股虧損0.29美元（0.29美元）下降了89.66％。該公司公佈的季度銷售額爲153萬美元，比分析師普遍預期的86萬美元高出77.67％。這比去年同期的105萬美元銷售額增長了45.39％。